Inmune Bio, Inc. — Director's Dealing 2024

May 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2024-05-14

Reporting Person: Baracchini Edgardo Jr (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-14	Option (right to buy)	$9.92	A	12500	Acquired	2034-05-13	Common Stock (12500)	Direct

Footnotes

F1: Granted pursuant to the 2021 Stock Incentive Plan. The Option will become vested and exercisable 1/12th every month until the Option is 100% vested which shall occur on the one-year anniversary of the grant date.